Top Clinical Trials companies in Australia by Return on Capital Employed (ROCE)
Australia
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
26.78%
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
| 2 |
18.36%
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
|
| 3 |
11.47%
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
| 4 |
10.70%
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
| 5 |
6.73%
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
| 6 |
2.85%
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
| 7 |
-1.43%
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
|
| 8 |
-9.73%
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
| 9 |
-24.36%
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
| 10 |
-218.64%
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
Frequently Asked Questions
-
Which Clinical Trials company in Australia has the highest Return on Capital Employed (ROCE) ?
The Clinical Trials company in Australia with the highest Return on Capital Employed (ROCE) is Clinuvel Pharmaceuticals Limited (ASX: CUV.AX) at 26.78%.
-
Which Clinical Trials company in Australia has the lowest Return on Capital Employed (ROCE) ?
The Clinical Trials company in Australia with the lowest Return on Capital Employed (ROCE) is Anteris Technologies Ltd (ASX: AVR.AX) at -218.64%.
-
What are the top 10 Clinical Trials companies in Australia by Return on Capital Employed (ROCE) ?
The top 10 Clinical Trials companies in Australia by Return on Capital Employed (ROCE) are Clinuvel Pharmaceuticals Limited, Cogstate Limited, CSL Limited, Australian Clinical Labs Limited, Telix Pharmaceuticals Limited, PolyNovo Limited, Monash IVF Group Limited, Mesoblast Limited, Immutep Limited and Anteris Technologies Ltd.
-
What are the bottom 10 Clinical Trials companies in Australia by Return on Capital Employed (ROCE) ?
The bottom 10 Clinical Trials companies in Australia by Return on Capital Employed (ROCE) are Anteris Technologies Ltd, Immutep Limited, Mesoblast Limited, Monash IVF Group Limited, PolyNovo Limited, Telix Pharmaceuticals Limited, Australian Clinical Labs Limited, CSL Limited, Cogstate Limited and Clinuvel Pharmaceuticals Limited.
